Table 2.
Study population characteristics and impact of socio-demographic and clinical factors on adherence in 1-year follow-up.
| Parameter | Variable | Total sample | Adherence in 1-year follow-up | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ACEI | P2Y12 receptor inhibitor | Statins | |||||||
| n | % | % | p | % | p | % | p | ||
| Gender | Female | 60 | 26.7 | 64.9 (± 31.8) | 0.4952 | 66.7 (± 29.7) | 0.4068 | 56.5 (± 40.9) | 0.2566 |
| Male | 165 | 73.3 | 68.0 (± 31.9) | 69.7 (± 35.6) | 49.4 (± 42.6) | ||||
| Age | < 65 | 129 | 57.3 | 71.5 (± 31.0) | 0.0071 | 61.3 (± 36.3) | 0.6520 | 64.6 (± 34.2) | 0.4936 |
| ≥ 65 | 96 | 42.7 | 61.2 (± 32.1) | 61.9 (± 31.5) | 65.3 (± 29.2) | ||||
| Employment status | Employed | 93 | 41.3 | 74.2 (± 30.3) | 0.0023 | 60.8 (± 37.3) | 0.6296 | 64.6 (± 36.3) | 0.6445 |
| Unemployed | 13 | 5.8 | 46.2 (± 39.3) | 70.4 (± 28.2) | 69.9 (± 30.8) | ||||
| Old age pensioner | 91 | 40.4 | 61.0 (± 31.2) | 60.3 (± 31.0) | 63.4 (± 28.2) | ||||
| Disability living allowance recipient | 28 | 12.4 | 73.0 (± 28.2) | 63.2 (± 37.9) | 64.9 (± 31.3) | ||||
| Education | Primary | 30 | 13.3 | 53.9 (± 38.6) | 0.1554 | 66.0 (± 30.8) | 0.788 | 62.1 (± 34.1) | 0.9679 |
| Vocational | 83 | 36.9 | 65.0 (± 32.8) | 62.1 (± 32.0) | 64.3 (± 31.6) | ||||
| Secondary | 82 | 36.4 | 73.7 (± 26.2) | 60.9 (± 36.8) | 65.5 (± 31.1) | ||||
| Higher | 30 | 13.3 | 67.6 (± 33.5) | 56.1 (± 38.1) | 64.1 (± 35.3) | ||||
| Economic status | Very good | 14 | 6.2 | 53.4 (± 37.3) | 0.1129 | 44.4 (± 37.0) | 0.2462 | 53.4 (± 38.9) | 0.4821 |
| Satisfactory | 199 | 88.4 | 69.1 (± 30.7) | 62.0 (± 34.3) | 64.9 (± 31.7) | ||||
| Bad | 12 | 5.3 | 52.9 (± 38.5) | 68.3 (± 26.2) | 67.8 (± 32.6) | ||||
| Very bad | 0 | 0 | 0 | 0 | 0 | ||||
| Marital status | Unmarried | 25 | 11.1 | 53.9 (± 36.2) | 0.0244 | 62.7 (± 30.2) | 0.8057 | 54.9 (± 36.4) | 0.3877 |
| Widowed | 33 | 14.7 | 60.4 (± 34.3) | 62.7 (± 37.5) | 64.9 (± 30.7) | ||||
| Married | 167 | 74.2 | 70.4 (± 30.2) | 61.1 (± 34.3) | 65.8 (± 31.6) | ||||
| Place of residence | City | 161 | 71.6 | 66.7 (± 32.3) | 0.7474 | 64.6 (± 33.5) | 0.0438 | 64.0 (± 31.1) | 0.4810 |
| The country | 64 | 28.4 | 68.4 (± 31.5) | 54.2 (± 35.1) | 65.7 (± 34.8) | ||||
| History of CAD | Yes | 102 | 45.3 | 64.1 (± 32.3) | 0.2751 | 60.2 (± 34.6) | 0.7585 | 61.8 (± 33.9) | 0.6201 |
| No | 123 | 54.7 | 69.0 (± 31.5) | 62.3 (± 34.1) | 65.9 (± 31.1) | ||||
| Prior MI | Yes | 64 | 28.4 | 58.3 (± 31.8) | 0.0050 | 57.5 (± 34.5) | 0.2637 | 58.3 (± 31.8) | 0.0016 |
| No | 161 | 71.6 | 70.9 (± 31.2) | 63.3 (± 34.1) | 70.9 (± 31.2) | ||||
| Prior PTCA | Yes | 82 | 36.4 | 61.6 (± 32.1) | 0.0210 | 56.6 (± 34.2) | 0.1114 | 51.2 (± 43.1) | 0.8148 |
| No | 143 | 63.6 | 70.7 (± 31.3) | 64.3 (± 34.0) | 51.4 (± 41.7) | ||||
| Prior CABG | Yes | 34 | 15.1 | 57.2 (± 33.6) | 0.0543 | 46.9 (± 34.1) | 0.0105 | 61.6 (± 34.6) | 0.7224 |
| No | 191 | 84.9 | 69.0 (± 31.2) | 64.1 (± 33.7) | 65.0 (± 31.7) | ||||
| Hyperlipidemia | Yes | 151 | 67.6 | 65.5 (± 31.2) | 0.1211 | 57.9 (± 34.7) | 0.0313 | 63.9 (± 31.9) | 0.6007 |
| No | 73 | 32.4 | 70.6 (± 33.1) | 68.8 (± 32.3) | 65.6 (± 32.7) | ||||
| Diabetes | Yes | 63 | 28.0 | 68.2 (± 31.4) | 0.7770 | 64.7 (± 33.0) | 0.5150 | 63.5 (± 33.2) | 0.9160 |
| No | 157 | 71.0 | 66.8 (± 32.1) | 60.5 (± 34.6) | 64.8 (± 31.8) | ||||
| Hypertension | Yes | 165 | 73.3 | 67.4 (± 32.1) | 0.8188 | 59.3 (± 35.0) | 0.1763 | 64.5 (± 31.8) | 0.9906 |
| No | 60 | 26.7.0 | 66.5 (± 31.4) | 67.4 (31.6) | 63.3 (± 33.2) | ||||
| Smoking status (current) | Yes | 85 | 37.8 | 64.8 (± 31.8) | 0.3086 | 63.5 (± 33.6) | 0.4828 | 61.0 (± 33.0) | 0.1993 |
| No | 140 | 62.2 | 68.7 (± 31.9) | 60.3 (± 34.7) | 66.6 (± 31.5) | ||||
CAD coronary artery disease, MI myocardial infarction, PTCA percutaneous transluminal coronary angioplasty, CABG coronary artery by-pass graft.
Bold values indicate p < 0.05.